The study to investigate the living body control function of "Koiaona", which is a cultivar of the kale highly including carotenoids and glucosinolates : a randomized, double-blinded, placebo-controlled trial.
- Conditions
- /A(healthy adults)
- Registration Number
- JPRN-UMIN000028707
- Lead Sponsor
- Kyoto Prefectural University Of Medicine
- Brief Summary
npublished
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 43
Not provided
1) Smokers 2)Those who are taking drugs for disease treatment 3) serious heart disease [heart failure, myocardial infarction, myocarditis, etc.] liver disease [liver failure symptoms (fulminant hepatitis ),patients with cirrhosis of the liver, liver tumor], renal disease [nephrotic syndrome, renal failure (acute and chronic), uremia, merged, etc. hydronephrosis] 4) Those who have participated in other clinical trials within before consent get one month, and those who are currently participating in other clinical trials. 5) At the physician's judgment, who it is determined that there is a possibility that either increased risk to the subject, or sufficient data not obtained 6) Those who take antibiotics within before consent get one month 7) Those who currently take health foods
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biomarkers of blood lipids such as LDL-C, HDL-C and TG will be measured as primary endpoint. The changes will be compared within each group and between the treatment groups.
- Secondary Outcome Measures
Name Time Method As secondary endpoints, following items will be evaluated; blood examination involving oxidative stress and special items such as s-LOX1, carotenoid, inflammation, mitochondrial function index, urinalysis, physiological parameters, variety and ratio of bacteria in stool and meal nourishment.